510(k) Report

510(k) · Cleared

Cleared

Biasol Liquid Concentrates, Add'l Acid Concentrate

K895199510(k) TraditionalCleared Dec 13, 1989117-day reviewClass II21 CFR 876.5820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baxter Healthcare Corp · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Cleared on Dec 13, 1989 after a 117-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 3 later devices descend from it.

Decided
Dec 13, 1989
Review
117 days
Class
Class II
Product code
KPO
Recalls
None
Predicates
0

3 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared2015: 1 descendant cleared2021: 1 descendant cleared1990200020102020
  1. This deviceK895199 Biasol Liquid Concentrates, Add'l Acid ConcentrateBaxter Healthcare Corp · 1989
  2. Descendant · cites it directly · 2 of its ownK041428 Accusol Dialysis SolutionBaxter Healthcare Corp · 2004
  3. Descendant · 2 generations on · 1 of its ownK150966 HMB32Haemopharm Biofluids S.R.L. · 2015
  4. Descendant · 3 generations on · 0 of its ownK212052 HMB32 Dialysis SolutionHaemopharm Biofluids S.R.L. · 2021

Most influential descendants

Showing 3 of 3 · See all
  • K041428Accusol Dialysis SolutionBaxter Healthcare Corp · 2004 · cites it directly2descendants
  • K150966HMB32Haemopharm Biofluids S.R.L. · 2015 · 2 generations on1descendant
  • K212052HMB32 Dialysis SolutionHaemopharm Biofluids S.R.L. · 2021 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K895199Biasol Liquid Concentrates, Add'l Acid ConcentrateBaxter Healthcare Corp1989—
+1K041428Accusol Dialysis SolutionBaxter Healthcare Corp2004—
+2K150966HMB32Haemopharm Biofluids S.R.L.2015—
+3K212052HMB32 Dialysis SolutionHaemopharm Biofluids S.R.L.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
201510
202110
FIG. 1 — Lineage of K895199, 1989–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPO device

  1. #1 K233159 pureFLOW 402, pureFLOW 400, pureFLOW 406…score 14.5 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K041428Accusol Dialysis SolutionBaxter Healthcare Corp20042

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K041428 (Baxter Healthcare Corp, 2004) has gone furthest, with 2 descendants of its own.

How does its category compare?

All KPO devices

KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPO

2in 2025

2007: 22008: 22009: 12011: 12012: 22013: 12014: 22015: 12016: 12017: 32018: 22020: 52021: 12022: 22023: 32024: 32025: 22026 (partial year): 2
2007high 5 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPO

112in 2024

2017: 192 days median2020: 270 days median2023: 263 days median2024: 112 days median
2007high 270 (2020) · low 112 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPO

6in 2025

2007: 52008: 22009: 12011: 22012: 102015: 32016: 12017: 12018: 112019: 12020: 312022: 22024: 12025: 62026 (partial year): 9
2007high 31 (2020) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KPO

95in 2025

2007: 52008: 82009: 32010: 1072011: 2232012: 702013: 3,8972014: 15,9162015: 8,3402016: 2402017: 802018: 972019: 792020: 2442021: 632022: 252023: 592024: 2592025: 95
2007high 15,916 (2014) · low 3 (2009)2025

MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—55
20082—28
20091—13
20100—0107
20111—2223
20122—1070
20131—03,897
20142—015,916
20151—38,340
20161—1240
20173192180
20182—1197
20190—179
2020527031244
20211—063
20222—225
20233263059
202431121259
20252—695
20262—9—
Cite this page

510(k) Report. “K895199: Biasol Liquid Concentrates, Add'l Acid Concentrate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K895199

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026